| pubmed-article:3655656 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0017355 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0205103 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0015980 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0596138 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C1704735 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:3655656 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:3655656 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3655656 | pubmed:dateCreated | 1987-11-12 | lld:pubmed |
| pubmed-article:3655656 | pubmed:abstractText | In conclusion, our observations indicate that the constitutive MHC class I expression is regulated by autocrine production of IFN-beta 1. TNF-alpha acts as an enhancer of the autocrine production of IFN-beta 1, and consequently as an enhancer of the MHC class I expression and viral protection. | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3655656 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3655656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3655656 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3655656 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:3655656 | pubmed:issn | 0022-1007 | lld:pubmed |
| pubmed-article:3655656 | pubmed:author | pubmed-author:BuurmanW AWA | lld:pubmed |
| pubmed-article:3655656 | pubmed:author | pubmed-author:van DammeJJ | lld:pubmed |
| pubmed-article:3655656 | pubmed:author | pubmed-author:LeeuwenbergJ... | lld:pubmed |
| pubmed-article:3655656 | pubmed:author | pubmed-author:JeunhommeG... | lld:pubmed |
| pubmed-article:3655656 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3655656 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:3655656 | pubmed:volume | 166 | lld:pubmed |
| pubmed-article:3655656 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3655656 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3655656 | pubmed:pagination | 1180-5 | lld:pubmed |
| pubmed-article:3655656 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:meshHeading | pubmed-meshheading:3655656-... | lld:pubmed |
| pubmed-article:3655656 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3655656 | pubmed:articleTitle | Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression. | lld:pubmed |
| pubmed-article:3655656 | pubmed:affiliation | Department of Surgery, University of Limburg, Maastricht, The Netherlands. | lld:pubmed |
| pubmed-article:3655656 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3655656 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3655656 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3655656 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3655656 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3655656 | lld:pubmed |
